Admission Date:  [**2194-10-20**]              Discharge Date:   [**2194-10-25**]  Date of Birth:  [**2138-6-27**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**Last Name (NamePattern1) 4377**] Chief Complaint: multiple PE  Major Surgical or Invasive Procedure: none   History of Present Illness: 56M w/diffuse Bcell lymphoma stage IV C2D12 of daEPOCH with recent line associated RUE DVT on fondaparinux presenting with palpatations and dyspnea found to have multiple PEs on CTA.
Patient discharged on metoprolol and fondaparinoux.
Heparin bolused and gtt begun in ED as pt has missed AM fondux.
Denies chest pain, chest pressure, palpitations, or weakness.
- [**2194-9-8**] CT torso without obvious adenopathy, thoracic, abdominal, or pelvic pathology.
- [**2194-9-18**] C1D1 R-da-[**Hospital1 **] (rituximab 375 mg/m2, etoposide 50 mg/m2, doxorubicin 10 mg/m2, vincristine 0.5 mg, cyclophosphamide 750 mg/m2, Prednisone 100 mg) c/b afib w RVR.
- [**2194-10-9**] C2 R-da-[**Hospital1 **] with 20% increase of etoposide, doxorubicin, and cyclophosphamide for good ANC in C1 (rituximab 375 mg/m2, etoposide 60 mg/m2, doxorubicin 12 mg/m2, vincristine 0.5 mg, cyclophosphamide 900 mg/m2, prednisone 100 mg).
- Remote h/o provoked DVT of LE after a long plane ride   Social History: - Tobacco: Rare cigars in his youth.
Physical Exam: Physical Exam on Admission:  Vitals: BP: 108/89 P:87 R:16 18 O2: 98%RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRLA, MMM, OP without exudates or lesions, Neck: supple, JVP not elevated, shotty cervical LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU: no foley Ext: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema, no calf tenderness  Physical Exam on Discharge:  Unchanged from admission  Pertinent Results: Lab Results on Admission: [**2194-10-20**] 11:41PM   PT-12.6 PTT-122.5* INR(PT)-1.1 [**2194-10-20**] 02:48PM   GLUCOSE-101* UREA N-15 CREAT-0.7 SODIUM-136 POTASSIUM-4.3 CHLORIDE-102 TOTAL CO2-27 ANION GAP-11 [**2194-10-20**] 02:48PM   estGFR-Using this [**2194-10-20**] 02:48PM   ALT(SGPT)-118* AST(SGOT)-48* ALK PHOS-102 TOT BILI-0.3 [**2194-10-20**] 02:48PM   LIPASE-34 [**2194-10-20**] 02:48PM   ALBUMIN-3.9 CALCIUM-9.0 PHOSPHATE-4.1 MAGNESIUM-2.1 [**2194-10-20**] 02:48PM   WBC-2.9*# RBC-3.60* HGB-10.0* HCT-29.6* MCV-82 MCH-27.8 MCHC-33.8 RDW-20.0* [**2194-10-20**] 02:48PM   WBC-2.9*# RBC-3.60* HGB-10.0* HCT-29.6* MCV-82 MCH-27.8 MCHC-33.8 RDW-20.0* [**2194-10-20**] 02:48PM   NEUTS-75.8* LYMPHS-16.9* MONOS-1.3* EOS-5.8* BASOS-0.3 [**2194-10-20**] 02:48PM   PLT COUNT-269 [**2194-10-20**] 02:48PM   PT-11.7 PTT-30.4 INR(PT)-1.0  Imaging: [**10-20**] CTA Chest: IMPRESSION: 1.
2) Possibly duplicated left subclavian vein with thrombosis of one of the paired left subclavian veins.
The proximal extent of the clot is not well seen on this study and further assessment of thrombus noted as well as vein anatomy can be obtained by MRV or CTV if indicated  [**10-22**] Echo: IMPRESSION: Normal regional and global biventricular systolic function.
Microbiology: Blood cultures: no growth  Lab results on Discharge:  [**2194-10-25**] 01:00AM BLOOD WBC-35.2* RBC-3.01* Hgb-8.6* Hct-25.0* MCV-83 MCH-28.6 MCHC-34.4 RDW-22.4* Plt Ct-175 [**2194-10-25**] 01:00AM BLOOD Neuts-61 Bands-3 Lymphs-5* Monos-3 Eos-3 Baso-0 Atyps-1* Metas-2* Myelos-2* Promyel-2* NRBC-1* Other-18* [**2194-10-25**] 01:00AM BLOOD Hypochr-NORMAL Anisocy-2+ Poiklo-1+ Macrocy-1+ Microcy-2+ Polychr-OCCASIONAL Ovalocy-1+ Tear Dr[**Last Name (STitle) 833**] [**2194-10-25**] 06:30AM BLOOD PT-17.1* PTT-71.0* INR(PT)-1.5* [**2194-10-22**] 04:47AM BLOOD Gran Ct-454* [**2194-10-25**] 01:00AM BLOOD Glucose-111* UreaN-9 Creat-0.8 Na-144 K-3.8 Cl-107 HCO3-26 AnGap-15 [**2194-10-25**] 01:00AM BLOOD ALT-98* AST-59* LD(LDH)-435* AlkPhos-127 TotBili-0.3 [**2194-10-22**] 04:47AM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-22**] 12:35PM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-22**] 08:45PM BLOOD CK-MB-2 cTropnT-<0.01 [**2194-10-25**] 01:00AM BLOOD Calcium-9.4 Phos-5.4* Mg-1.9 [**2194-10-23**] 04:52PM BLOOD Type-ART pO2-82* pCO2-39 pH-7.44 calTCO2-27 Base XS-1 Intubat-NOT INTUBA [**2194-10-24**] 01:16PM BLOOD Lactate-2.0  Brief Hospital Course: Primary Reason for Hospitalization: Patient is a 56M w/diffuse Bcell lymphoma stage IV who recently completed daEPOCH (D12 on admission) and with recent line associated RUE DVT on fondaparinux who presented with palpatations and dyspnea found to have multiple PEs on CTA.
Patient reports compliance with SQ fondaparinux 7.5 mg/0.6 mL SQ since previous discharge.
Patient was started on heparin and transitioned to Lovenox.
He was on lepirudin gtt for 2 days while awaiting results of heparin-dependent antibody test which showed no antibody detected.
He was discharged on Lovenox 1mg/kg [**Hospital1 **].
Patient was continued on neupogen through nadir.
His beta blockers were held in the acute setting and patient did have one brief episode of afib which resolved with re-starting of the beta blocker.
Infection PPX: Patient was discharged with Bactrim DS three times weekly and acyclovir 3 times daily.
TRANSITIONS IN CARE: Patient will follow up with his outpatient oncologist for further management.
Medications on Admission: # fondaparinux 7.5 mg/0.6 mL Syringe Sig: One (1)  Subcutaneous once a day for 30 days.
# acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours).
# metoprolol succinate 100 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day.
# lorazepam 1 mg Tablet Sig: 1-2 Tablets PO every six (6) hours as needed for Nausea, anxiety, insomnia.
# ZOFRAN ODT 4 mg Tablet, Rapid Dissolve Sig: [**2-2**] Tablet, Rapid Dissolves PO every eight (8) hours as needed for nausea.
# oxycodone 5 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for Pain.
(no longer taking) # docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation.
# senna 8.6 mg Tablet Sig: 1-2 Tablets PO twice a day as needed for Constipation.
Bactrim DS 800-160 mg Tablet Sig: One (1) Tablet PO three times weekly on Monday, Wednesday, Friday.
# Neupogen 480 mcg/0.8 mL Syringe Sig: One (1) syringe Injection once a day: daily starting the evning of [**2194-10-15**].
Disp:*14 syringes* Refills:*2*   Discharge Medications: 1. enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) syringe Subcutaneous Q12H (every 12 hours).
Disp:*60 syringe* Refills:*2* 2. sulfamethoxazole-trimethoprim 800-160 mg Tablet Sig: One (1) Tablet PO 3X/WEEK (MO,WE,FR).
3. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours).
4. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO twice a day.
Disp:*60 Tablet(s)* Refills:*2* 5. lorazepam 1 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for anxiety, insomnia: Do not drive or operate heavy machinery while taking this medication.
Disp:*60 Tablet(s)* Refills:*1* 6. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain: do not drive or operate heavy machinery while taking this medication.
7. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for Constipation.
8. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
9. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) packet PO DAILY (Daily) as needed for constipation.
10. ondansetron 4 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO Q8H (every 8 hours) as needed for nausea.
11. bisacodyl 5 mg Tablet, Delayed Release (E.C.)
START taking Lovenox 80mg by subcutaneous injection every 12 hours 2.
STOP taking Fondiparinaux 3.
STOP taking neupogen injections 4.
CHANGE metoprolol to the tartrate form, 25mg by mouth twice daily  Please keep all of your follow-up appointments and take other medications as prescribed.
